This study confirmed that the FAT1 mutation rate was significantly higher in HPV(−) than HPV(+) patients in this cohort, suggesting FAT1 mutation may play more critical roles in HPV(−) than in HPV(+) HNSCC. Here, FAT1 is linked to head and neck squamous cell carcinoma.